Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Valsad Institute Of Medical Sciences Limited, is an unlisted public company incorporated on 19 March, 2020. It is classified as a public limited company and is located in Valsad, Gujarat. It's authorized share capital is INR 27.00 cr and the total paid-up capital is INR 27.00 cr.
The current status of Valsad Institute Of Medical Sciences Limited is - Active.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 1
Total Amount : 39.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Kmp | Aditi Sandeep Desai | <HIDDEN> | 2 years |
| Director | Dhananjay Thakorbhai Desai | 00049574 | 2 years |
| Director | Pramod Hari Lele | 00106902 | 2 years |
| Director | Sunil Sumant Joshi | 00198728 | 2 years |
| Director | Sandeep Sumantrai Desai | 02667533 | 5 years |
| Director | Ajitsingh Mohindersingh Batra | 02780698 | 2 years |
| Director | Hitendrasinh Ranchhodbhai Padhiyar | 08785035 | 4 years |
| Director | Sunil Kanubhai Choksi | 09249579 | 3 years |
| Director | Nishtha Sunilbhai Lalbhai | 09566725 | 2 years |
| Kmp | Nilay Hitendrabhai Jatakia | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| OSTERN PVT LTD |
Active
|
79.2 L | 1 | West Bengal |
| ECOPLAST LIMITED |
Active
|
3.0 Cr | 1 | Gujarat |
| RUTH FINVEST PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
| SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED |
Active
|
1.8 Cr | 1 | Gujarat |
| JAN-MANGAL PHARMACY FOUNDATION |
Active
|
2.0 L | 1 | Gujarat |
| CHOICE NATURALS PRIVATE LIMITED |
Strike Off
|
10.0 L | 1 | Maharashtra |
| BIONOVA SOLUTIONS PRIVATE LIMITED |
Active
|
3.0 Cr | 1 | Gujarat |
| PHARMA BASE INDIA PRIVATE LIMITED |
Active
|
39.6 Cr | 1 | Maharashtra |
| GELNOVA LABORATORIES (INDIA) PRIVATE LIMITED |
Active
|
1.3 Cr | 1 | Maharashtra |
| FULFORD (INDIA) LIMITED |
Active
|
3.8 Cr | 1 | Maharashtra |
| GHARPOCH CONNECT PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| CHITPAVAN FOUNDATION |
Active
|
5.2 L | 1 | Maharashtra |
| ATUL BIOSCIENCE LIMITED |
Active
|
29.0 Cr | 1 | Gujarat |
| HEALTHBRIDGE ADVISORS PRIVATE LIMITED |
Active
|
45.0 L | 1 | Maharashtra |
| ATUL HOSPITALITY LIMITED |
Active
|
6.0 L | 2 | Gujarat |
| JAYATI INFRASTRUCTURE LIMITED |
Active
|
9.0 L | 2 | Gujarat |
| ATUL INFOTECH PRIVATE LIMITED |
Active
|
30.0 L | 1 | Gujarat |
| ATUL NIVESH LIMITED |
Active
|
2.5 Cr | 1 | Gujarat |
| ATUL FIN RESOURCES LIMITED |
Active
|
15.6 Cr | 1 | Gujarat |
| BIYABAN AGRI LIMITED |
Active
|
1.1 Cr | 2 | Rajasthan |
| RAJA DATES LIMITED |
Active
|
4.1 Cr | 2 | Rajasthan |
| AASTHAN DATES LIMITED |
Active
|
2.1 Cr | 2 | Rajasthan |
| ATUL BIO SPACE LIMITED |
Active
|
11.3 Cr | 2 | Gujarat |
| VALSAD MRI & CT SCAN PRIVATE LIMITED |
Active
|
50.0 L | 1 | Gujarat |
| ATUL AYURVEDA LIMITED |
Active
|
8.0 L | 1 | Gujarat |
| OSIA INFRASTRUCTURE LIMITED |
Active
|
3.9 Cr | 1 | Gujarat |
| SEHAT FOODS LIMITED |
Active
|
10.0 L | 1 | Gujarat |
The incorporation date of VALSAD INSTITUTE OF MEDICAL SCIENCES LIMITED is 19 March, 2020
The authorized share capital of VALSAD INSTITUTE OF MEDICAL SCIENCES LIMITED is INR ₹ 27.0 Cr.
The paid-up capital of VALSAD INSTITUTE OF MEDICAL SCIENCES LIMITED is INR ₹ 27.0 Cr.
The registered address of VALSAD INSTITUTE OF MEDICAL SCIENCES LIMITED is Survey No 644 Pardi Road Khokhra Faliya Parnera (Urban) Valsad Valsad Gujarat - 396020
The CIN number of VALSAD INSTITUTE OF MEDICAL SCIENCES LIMITED is U85320GJ2020PLC113263.
Expand
Delete
Collapse
See
details
